Journals / Okmeydanı Tıp Dergisi / 2016 / Cilt: 32 - Sayı: 4

The Effectivity of Using Levonorgestrel Releasing Intrauterine Devive in the Treatment of Abnormal Uterine Bleeding

Anormal Uterin Kanama Tedavisinde Levonorgestrel Salgılayan Rahim İçi Araç Kulanımının Etkinliği

Pages
195–197
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: Levonorgestrel-releasing intrauterine device in the treatment of abnormal uterine bleeding is a reliable and effective treatment.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: To evaluate the menstrual bleeding character, hemoglobin, hematocrit, and endometrial biopsy results before and after 1 year of treatment with Levonorgestrelreleasing intrauterine device in patients with abnormal uterine bleeding.
📊
Key Findings & Data:Material and Methods: 77 female patients in reproductive age, who have been treated with levonorgestrel-releasing intrauterine device for abnormal uterine bleeding, were enrolled in the study.
💡
Conclusion & Impact:Conclusion: Levonorgestrel-releasing intrauterine device in the treatment of abnormal uterine bleeding is a reliable and effective treatment.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: To evaluate the menstrual bleeding character, hemoglobin, hematocrit, and endometrial biopsy results before and after 1 year of treatment with Levonorgestrelreleasing intrauterine device in patients with abnormal uterine bleeding. Material and Methods: 77 female patients in reproductive age, who have been treated with levonorgestrel-releasing intrauterine device for abnormal uterine bleeding, were enrolled in the study. Findings of the patients before and after the treatment were compared. Results: Significant changes in menstrual bleeding patterns were detected in 58 of 77 patients (75.32%) treated with Levonorgestrel-releasing intrauterine device for abnormal uterine bleeding. Increase in hemoglobin and hematocrit values were determined. 11 patients (14.28%) did not experience any change in vaginal bleeding complaints. Conclusion: Levonorgestrel-releasing intrauterine device in the treatment of abnormal uterine bleeding is a reliable and effective treatment.

Özet

Amaç: Anormal uterin kanama tanısıyla levonorgestrel salgılayan rahim içi araç uygulanan hastalarda tedavi öncesi ve 1 yıl sonraki menstrüel kanama karakterini, hemoglobin, hematokrit ve endometrial biyopsi sonuçlarını değerlendirmek. Gereç ve Yöntem: Anormal uterin kanama tanısı almış ve tedavi amaçlı levonorgestrel salgılayan rahim içi araç uygulanmış, reprodüktif dönemdeki 77 kadın hasta çalışmaya alındı. Hastaların tedavi öncesi ve sonrası bulguları karşılaştırıldı.Bulgular: Anormal uterin kanama tanısı ile levonorgestrel salgılayan rahim içi araç tedavisi uygulanan 77 hastanın 58'inde (%75,32) menstrüel kanama paterninde olumlu ve anlamlı değişiklik saptandı. Hemoglobin ve hematokrit değerlerinde artış tespit edildi. Hastaların 11'inin (%14,28) vajinal kanama yakınmalarında değişiklik olmadı.Sonuç: Anormal uterin kanama tedavisinde levonorgestrel salgılayan rahim içi araç uygulaması güvenilir ve etkin bir tedavi yöntemidir

🔖

Cite This Article

PUL, S., MİHMANLI, V., TAHAOĞLU, A. E., KILIÇKAYA, A., MİRZA, T. (2016). The Effectivity of Using Levonorgestrel Releasing Intrauterine Devive in the Treatment of Abnormal Uterine Bleeding. Okmeydanı Tıp Dergisi, Cilt: 32 - Sayı: 4, 195–197. https://ajindex.com/articles/291733

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (4)

  1. Speroff L, Glass RH, Kase NG. Klinik Jinekolojik En- dokrinoloji ve İnfertilite In: Ayhan A, Başaran A ed. Disfonksiyonel Uterus Kanaması. Güneş Tıp Kitabevi 2007; 547-71. Desai RM. Efficacy of levonorgestrel releasing intra- uterine system for the treatment of menorrhagia due to benign uterine lesions in perimenopausal women. J Midlife Health 2012;1:20-3. http://dx.doi.org/10.4103/0976-7800.98812
  2. Kaunitz AM, Bissonnette F, Monteiro I, Lukkari-lax E, DeSanctis Y. Levonorgestrel releasing intrauterine system for heavy menstrual bleeding improves hemog- lobin and ferritin levels. Contraception 2012;5:452-7. http://dx.doi.org/10.1016/j.contraception.2012.07.018
  3. Luukkainen T, Allonen H, Haukkamaav M. Effective contraception with the levonorgestrel-releasing intrau- terine device: 12 month report of an European multi- center study. Contraception 1987;36:169-79. http://dx.doi.org/10.1016/0010-7824(87)90012-6
  4. Gorgen H, Api M, Akca A, Cetin A. Use of the Levonorgestrel-IUS in the treatment of menorrhagia: assessment of quality of life in Turkish users. Arch Gynecol Obstet 2009;279:835-40. http://dx.doi.org/10.1007/s00404-008-0834-x Nelson AL. Levonorgestrel intrauterine system: a first- line medical treatment for heavy menstrual bleeding. Women's Health 2010;6:347-56. http://dx.doi.org/10.2217/whe.10.16 Sivin I. Dose and age dependent ectopic pregnancy risks with intrauterine contraception. Obstet Gynecol 1991;78:291-8. http://dx.doi.org/10.2307/1966457